Melanotan I Nasal Spray peptide Details Melanotan I Nasal Spray Research Grade | Pre-Formulated Liquid Solution This nasal spray formulation delivers Melanotan I (MT-1, Afamelanotide) as a pre-formulated, sterile liquid solution for research use
In phase 2 trials, retatrutide patients lost approximately 24% of their initial weight and experienced a 1.7 to 2% decrease in A1C, which is an indicator of blood sugar levels
Theyve been designed to be taken alongside lifestyle changes that will enable you to eventually come off the medications and maintain your lower weight for the long term
Diabetes, Obesity & Metabolism, 22(6), 938946
2022;14(3):e22849
Everything, from your prescription to medication delivery, is handled in one seamless, integrated solution: Licensed Prescriber Access to qualified healthcare providers who can prescribe your medications as part of our complete service